High Content Screening Program adopted at the National Center for Drug Screening in China
Collaboration to expand HCS technology throughout China underway
The National Center for drug screening (NCDS) located in Shanghai, China and Cellomics, Inc. of Pittsburgh, Pennsylvania, U.S.A today announced a joint collaboration aimed at expanding the application of High Content Screening (HCS) in China. Affiliated with the Shanghai Institute of Materia Mecica, Chinese Academy of Sciences, the Center is a key national technology innovation base in drug discovery and development.
Cellomics, Inc., a privately held company, is recognized as the creator of and market leader in HCS, providing a unique cell-based platform to its global clients in pharmaceutical, biotechnology and academic institutions.
"We are very pleased to work with Cellomics as a strategic partner in the establishment of an HCS program at the Center," stated Dr. Ming-Wei Wang, Director of the NCDS. "By including the ArrayScan(R) HCS Reader with all of the Cellomics' software, reagents and expertise in the implementation of HCS, we are able to quickly execute our strategic plan for including high content cell-based assays in our drug discovery and development efforts," continued Dr. Wang.
"Our collaboration with Dr. Wang and the NCDS is critically important for Cellomics," replied Daniel J. Calvo, President and CEO of Cellomics. "Through this joint effort with China's leading drug discovery facility, we can expand our global leadership position in HCS into China and the surrounding region. We look forward to assisting this world-class laboratory in incorporating our technology into their research programs," continued Calvo.
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
